lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2646 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (326 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed82    
    Printed0    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2022  |  Volume : 54  |  Issue : 2  |  Page : 153
 

Role of Vitamin D in COVID-19: Correspondence


1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India

Date of Submission26-Nov-2021
Date of Decision10-Jan-2022
Date of Acceptance22-Mar-2022
Date of Web Publication10-May-2022

Correspondence Address:
Dr. Pathum Sookaromdee
Private Academic Consultant, 11 Bangkok 112 Bangkok 103320
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijp.ijp_897_21

Rights and Permissions



How to cite this article:
Sookaromdee P, Wiwanitkit V. Role of Vitamin D in COVID-19: Correspondence. Indian J Pharmacol 2022;54:153

How to cite this URL:
Sookaromdee P, Wiwanitkit V. Role of Vitamin D in COVID-19: Correspondence. Indian J Pharmacol [serial online] 2022 [cited 2022 May 18];54:153. Available from: https://www.ijp-online.com/text.asp?2022/54/2/153/344968




Sir,

We would like to share ideas on “Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.”[1] Singh et al. concluded that “Using Vitamin D as prophylaxis and/or chemotherapeutic treatment … of Vitamin D affecting many people worldwide.”[1] We agree that Vitamin D might play a role in the management of COVID-19. Trials might be useful. Considering trial, some important concerns are hereby discussed. First, it should assess the impact of genetic polymorphism. Vitamin D-binding protein polymorphism might be associated with outcome of Vitamin D supplementation in the COVID-19 treatment.[2] Additionally, if a trial will be performed, a background Vitamin D data of subjects should be assessed.

The effect of Vitamin D in COVID-19 might also be associated with some other modifiers. Sunlight exposure and estrogen interaction should be discussed. Estradiol is also proposed for its usefulness in managing COVID-19.[3] There might be an interesting co-advantage of both Vitamin D and estradiol in the management of COVID-19.

Financial support and sponsorship

Nil.

Conflicts of interest

The authors ask for waiving for any charge for this correspondence.



 
  References Top

1.
Singh S, Singh CM, Ranjan A, Kumar S, Singh DK. Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link. Indian J Pharmacol 2021;53:394-402.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Speeckaert MM, Delanghe JR. The potential significance of vitamin D binding protein polymorphism in COVID-19. Int J Infect Dis 2021;109:90.  Back to cited text no. 2
    
3.
Youn JY, Zhang Y, Wu Y, Cannesson M, Cai H. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells. Redox Biol 2021;46:102099.  Back to cited text no. 3
    




 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow